We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Porous Meniscus Implant Encourages Blood Vessel Growth

By HospiMedica staff writers
Posted on 01 May 2007
A new meniscus implant encourages the growth of blood vessels, promoting the natural growth of meniscus-like tissue to repair and heal the native tissue. More...


Actifit is a resorbable, extremely porous polymer scaffold material that was especially designed to encourage tissue growth and regeneration in the meniscus, a circular-shaped disc of cartilage tissue that act as a shock absorber in the knee. Although tough and durable, the biocompatible material remains soft enough to easily cut to shape and suture securely. The surgical procedure involves cutting back the damaged meniscus to an area with good blood supply. Actifit is then cut to fit, inserted into the void where the damaged meniscus was removed, and sutured in place. The patient should be able to resume a relatively normal, active life after a short rehabilitation period. Actifit is under development by Orteq Bioengineering (Cambridge, UK).

"Actifit is expected to allow a safe, simple procedure with the prospect of faster rehabilitation and reduced pain,” said Prof. Rene Verdonk of University Hospital (Gent, Belgium), the lead investigator in the European clinical trial, who performed the first surgical procedure. "This could be a new option for patients that will avoid the potential long term degenerative effects of removing damaged meniscal tissue.”

The medial and lateral menisci are fixed between the two weight-bearing surfaces within the knee, and as such can become "pinched” by the other structures of the knee between the joint when an injury occurs. Typically, the injury involves twisting on a bent knee. When this happens the menisci can become torn ("torn cartilage”). Meniscal tears, when surgery is indicated, are treated using arthroscopic surgery or mini open surgery.


Related Links:
Orteq Bioengineering
University Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.